We are live on
!
Find out more
FS
Financial Symmetry Portfolio holdings
AUM
$300M
1-Year Est. Return
23.79%
This Fund
S&P 500
This Quarter
Est. Return
+3.22%
1 Year Est. Return
+23.79%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$245M
AUM Growth
+$22.2M
(+10%)
Cap. Flow
+$14.9M
Cap. Flow
% of AUM
6.07%
Top 10 Holdings %
Top 10 Hldgs %
79.93%
Holding
62
New
8
Increased
24
Reduced
16
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dimensional US Core Equity 2 ETF
DFAC
|
+$2.3M |
| 2 |
Dimensional Ultrashort Fixed Income ETF
DUSB
|
+$1.99M |
| 3 |
Dimensional International Core Equity 2 ETF
DFIC
|
+$1.61M |
| 4 |
Dimensional Core Fixed Income ETF
DFCF
|
+$1.59M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$1.25M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$213K |
| 2 |
Apple
AAPL
|
+$146K |
| 3 |
Cisco
CSCO
|
+$120K |
| 4 |
Avantis US Equity ETF
AVUS
|
+$78.6K |
| 5 |
DFAI
Dimensional International Core Equity Market ETF
DFAI
|
+$69.3K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.19% |
| 2 | Consumer Discretionary | 0.79% |
| 3 | Healthcare | 0.61% |
| 4 | Communication Services | 0.39% |
| 5 | Financials | 0.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Mastercard
MA
$493B
| $268K | 0.11% |
470
| – | – |
|
52
Oracle
ORCL
$423B
| $257K | 0.1% |
1,317
| – | – |
|
53
AbbVie
ABBV
$435B
| $228K | 0.09% |
+1,000
| New | +$228K |
|
54
Vanguard Total Bond Market
BND
$161B
| $213K | 0.09% |
2,872
+28
| +1% | +$2.08K |
|
|
DXIV
55
Dimensional International Vector Equity ETF
DXIV
$216M
| $212K | 0.09% |
+3,255
| New | +$204K |
|
56
State Street Technology Select Sector SPDR ETF
XLK
$123B
| $211K | 0.09% |
1,468
| – | – |
|
57
Procter & Gamble
PG
$339B
| $207K | 0.08% |
1,445
-146
| -9% | -$21.5K |
|
58
Abbott
ABT
$187B
| $202K | 0.08% |
+1,615
| New | +$206K |
|
59
TXO Partners LP
TXO
$760M
| $134K | 0.05% |
12,568
| – | – |
|
|
PVCT
60
DELISTED
PROVECTUS BIOPHARMACEUTICALS, INC. (DE)
PVCT
| $570 | ﹤0.01% |
10,191
| – | – |
|
|
61
iShares Core S&P Mid-Cap ETF
IJH
$127B
| – | – |
-3,268
| Closed | -$213K |
|
Similar funds
RCA
UCB
KEM
RP
I
SC
FPCG
GB
Financial Symmetry's Q4 2025 Portfolio in Review
As of Q4 2025, Financial Symmetry held 62 positions worth $245M, up 10% from $223M the previous quarter. Its ten largest holdings account for 80% of the portfolio.
Financial Symmetry deployed $14.9M of net new capital in Q4 2025, opening 8 new positions and adding to 24 existing holdings. Its largest new stake was Vanguard Morningstar Mid-Cap Value ETF: 5,414 shares worth $960K.
By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.5% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $146K trimmed.
- Financial Symmetry's largest Q4 2025 buy was Vanguard Morningstar Mid-Cap Value ETF: 5,414 shares worth $960K.
- Financial Symmetry added most to Dimensional US Core Equity 2 ETF in Q4 2025, an estimated $2.3M increase.
- Financial Symmetry's biggest Q4 2025 reduction was Apple, cutting an estimated $146K.
- Financial Symmetry fully exited iShares Core S&P Mid-Cap ETF in Q4 2025, selling an estimated $213K.
- Financial Symmetry's ten largest holdings make up 80% of its $245M portfolio in Q4 2025.
- Financial Symmetry opened 8 new positions and closed 2 in Q4 2025.
- Financial Symmetry's portfolio value rose 10% quarter-over-quarter to $245M.
Based on Financial Symmetry's 13F filing for Q4 2025, filed 28 Jan 2026.